遗传性血管性水肿（H.A.N.E.）血浆中的激肽生成 - Suppr

Suppr

超能文献

Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.

作者信息

Donaldson V H, Rosen F S, Bing D H

出版信息

Adv Exp Med Biol. 1983;156:183-91.

PMID:6222633

Abstract

摘要

相似文献

Kinin generation in hereditary angioneurotic edema (H.A.N.E.) plasma.遗传性血管性水肿（H.A.N.E.）血浆中的激肽生成

Adv Exp Med Biol. 1983;156:183-91.

Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma.补体第二成分（C2）和纤溶酶在遗传性血管性水肿（H.A.N.E.）血浆激肽释放中的作用。

Trans Assoc Am Physicians. 1977;90:174-83.

Cleavage of the second component of complement by plasma proteases: implications in hereditary C1-inhibitor deficiency.血浆蛋白酶对补体第二成分的裂解：对遗传性C1抑制物缺乏症的影响。

Immunology. 1985 Nov;56(3):561-70.

[Correlation of complement system with coagulation, fibrinolysis, and kinin generation].补体系统与凝血、纤维蛋白溶解及激肽生成的相关性

Rinsho Ketsueki. 1976 Jan;17(1):1-14.

The challenge of hereditary angioneurotic edema.遗传性血管性水肿的挑战。

N Engl J Med. 1983 May 5;308(18):1094-5. doi: 10.1056/NEJM198305053081810.

C1 inhibitor and hereditary angioneurotic edema.C1 抑制剂与遗传性血管性水肿

Annu Rev Immunol. 1988;6:595-628. doi: 10.1146/annurev.iy.06.040188.003115.

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.遗传性血管性水肿：血浆激肽及血管通透性增强活性的特征

Clin Exp Immunol. 1994 Jan;95(1):22-8. doi: 10.1111/j.1365-2249.1994.tb06009.x.

C1 inhibitor deficiency: hereditary and acquired forms.C1 抑制剂缺乏症：遗传性和获得性形式。

J Investig Allergol Clin Immunol. 2001;11(4):211-9.

C1-inhibitor--biochemical properties and clinical applications.C1 抑制剂——生化特性与临床应用

Crit Rev Immunol. 1985;5(4):317-30.

Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of "spontaneous" formation of bradykinin.遗传性血管性水肿血浆中的激肽形成：反对激肽源自C2的证据及支持缓激肽“自发”形成的证据

J Allergy Clin Immunol. 1983 Jul;72(1):54-60. doi: 10.1016/0091-6749(83)90052-0.

引用本文的文献

The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会（WAO）/欧洲变态反应和临床免疫学会（EAACI）遗传性血管性水肿管理指南——2021年修订与更新

World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.

The International/Canadian Hereditary Angioedema Guideline.《国际/加拿大遗传性血管性水肿指南》

Allergy Asthma Clin Immunol. 2019 Nov 25;15:72. doi: 10.1186/s13223-019-0376-8. eCollection 2019.

Canadian hereditary angioedema guideline.加拿大遗传性血管性水肿指南。

Allergy Asthma Clin Immunol. 2014 Oct 24;10(1):50. doi: 10.1186/1710-1492-10-50. eCollection 2014.

WAO Guideline for the Management of Hereditary Angioedema.WAO 遗传性血管性水肿管理指南。

World Allergy Organ J. 2012 Dec;5(12):182-99. doi: 10.1097/WOX.0b013e318279affa.

Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities.遗传性血管性水肿：血浆激肽及血管通透性增强活性的特征

Clin Exp Immunol. 1994 Jan;95(1):22-8. doi: 10.1111/j.1365-2249.1994.tb06009.x.

Angioedema induced by a peptide derived from complement component C2.由补体成分C2衍生的一种肽引起的血管性水肿。

J Exp Med. 1988 Nov 1;168(5):1685-98. doi: 10.1084/jem.168.5.1685.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验